Page 19 - SaxoCell Annual Report22/23
P. 19
Advantages for new partners
The Saxocell future cluster is a beacon for personalized medicine in Saxony with national
and international appeal. The number of new academic and industrial partners is growing
steadily. The integration of new partners can take place at the beginning of the new
implementation phase in 2024 as well as at any time via SaxoCell e.V.. SaxoCell offers
exclusive advantages to new partners:
Access to innovative ATMPs from basic and applied research, platform
technologies, infrastructure, patients for clinical trials, and comprehensive
ATMP expertise
Access to potential customers and end users (e.g., for equipment and service
solution providers) as well as skilled personnel
Participation in joint educational activities and training of specialists,
support in regulatory issues and communication with the authorities
Investment opportunities for VC through increased spin-off activities of
SaxoCell partners, access to financing options for cost-intensive
development steps (public funding)
Increasing the visibility of the respective company
Become a key member of our growing network by contacting us at info@saxocell.de.
14
